INNOSPEC INC.

IOSP · XNAS

CIK 1054905fmd_105RQKPFJA24XQYDYRT3PYHEY9Manufacturing · Chemicals & Allied ProductsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	883	1,307	1,477	1,513	1,193	1,483	1,964	1,949	1,845	1,778
Cost of revenue	551	904	1,042	1,047	850	1,049	1,377	1,358	1,303	1,286
Gross profit	332	403	435	466	343	435	587	591	543	492
Research and development	25	31	33	35	31	37	39	49	57	51
Selling, general and administrative	217	244	261	281	237	267	361	381	305	285
Total operating expenses	234	278	302	316	309	303	399	430	365	363
Operating income	98	125	134	150	34	132	187	162	178	130
Interest expense	3	7	7	5	1	0	0	0	0	0
Interest and investment income	–	–	–	–	–	–	–	–	–	–
Other non-operating income (expense)	8	11	5	5	8	4	(2)	11	10	(1)
Income before taxes	103	128	132	150	40	134	185	174	41	138
Income tax expense	22	66	47	38	11	41	52	35	6	22
Net income from continuing operations	81	62	85	112	29	93	133	139	36	117
Net income	81	62	85	112	29	93	133	139	36	117